Albemarle (NYSE:ALB – Get Rating) up to date its FY 2022 earnings steerage on Monday. The corporate offered earnings per share steerage of $12.30-$15.00 for the interval, in comparison with the consensus earnings per share estimate of $10.88. The corporate issued income steerage of $5.80 billion-$6.20 billion, in comparison with the consensus income estimate of $5.44 billion.
ALB opened at $236.87 on Monday. The corporate has a market capitalization of $27.74 billion, a price-to-earnings ratio of 99.53, a P/E/G ratio of 0.69 and a beta of 1.52. The enterprise’s 50-day transferring common worth is $225.44 and its two-hundred day transferring common worth is $222.34. Albemarle has a 1 12 months low of $157.82 and a 1 12 months excessive of $291.48. The corporate has a debt-to-equity ratio of 0.33, a present ratio of 1.11 and a fast ratio of 0.63.
Albemarle (NYSE:ALB – Get Rating) final launched its earnings outcomes on Wednesday, Could 4th. The specialty chemical compounds firm reported $2.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.65. The enterprise had income of $1.13 billion for the quarter, in comparison with analyst estimates of $1.03 billion. Albemarle had a return on fairness of 10.35% and a web margin of seven.76%. Albemarle’s income was up 36.0% on a year-over-year foundation. Throughout the identical quarter within the prior 12 months, the corporate posted $1.10 earnings per share. Promote-side analysts anticipate that Albemarle will publish 13.4 earnings per share for the present fiscal 12 months.
This information will allow you to determine and execute an choices buying and selling technique that matches your particular wants and threat profile.
Take your buying and selling to the following degree with the Choices Technique Information.
The corporate additionally lately introduced a quarterly dividend, which will probably be paid on Friday, July 1st. Stockholders of file on Friday, June tenth will probably be given a $0.395 dividend. This represents a $1.58 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Thursday, June ninth. Albemarle’s payout ratio is 66.39%.
Numerous equities analysis analysts lately issued stories on ALB shares. Oppenheimer elevated their worth goal on Albemarle from $307.00 to $368.00 in a analysis report on Friday, Could sixth. UBS Group minimize Albemarle from a purchase score to a impartial score and minimize their goal worth for the inventory from $300.00 to $260.00 in a analysis word on Thursday, June 2nd. Jefferies Monetary Group restated a purchase score and set a $290.00 goal worth on shares of Albemarle in a analysis word on Monday, Could sixteenth. Wells Fargo & Firm upped their goal worth on Albemarle from $285.00 to $320.00 and gave the inventory an chubby score in a analysis word on Tuesday, Could twenty fourth. Lastly, KeyCorp elevated their worth goal on Albemarle from $215.00 to $217.00 and gave the corporate an underweight score in a analysis word on Tuesday, Could twenty fourth. Two analysts have rated the inventory with a promote score, 4 have given a maintain score and twelve have issued a purchase score to the inventory. Based on MarketBeat.com, the corporate at the moment has a consensus score of Purchase and a median goal worth of $281.21.
A number of institutional traders have lately purchased and bought shares of ALB. Wellington Administration Group LLP lifted its place in shares of Albemarle by 33.6% in the course of the 1st quarter. Wellington Administration Group LLP now owns 865,408 shares of the specialty chemical compounds firm’s inventory price $191,386,000 after shopping for a further 217,538 shares within the final quarter. Invesco Ltd. raised its holdings in shares of Albemarle by 14.3% within the 1st quarter. Invesco Ltd. now owns 1,247,801 shares of the specialty chemical compounds firm’s inventory price $275,952,000 after buying a further 155,848 shares in the course of the interval. Morgan Stanley raised its holdings in shares of Albemarle by 35.2% within the 2nd quarter. Morgan Stanley now owns 507,062 shares of the specialty chemical compounds firm’s inventory price $85,420,000 after buying a further 131,903 shares in the course of the interval. Vanguard Group Inc. raised its holdings in shares of Albemarle by 0.6% within the 1st quarter. Vanguard Group Inc. now owns 13,661,001 shares of the specialty chemical compounds firm’s inventory price $3,021,130,000 after buying a further 75,867 shares in the course of the interval. Lastly, Goldman Sachs Group Inc. raised its holdings in shares of Albemarle by 9.6% within the 1st quarter. Goldman Sachs Group Inc. now owns 392,636 shares of the specialty chemical compounds firm’s inventory price $86,831,000 after buying a further 34,534 shares in the course of the interval. 80.03% of the inventory is at the moment owned by hedge funds and different institutional traders.
Albemarle Firm Profile (Get Rating)
Albemarle Company develops, manufactures, and markets engineered specialty chemical compounds worldwide. It operates by means of three segments: Lithium, Bromine, and Catalysts. The Lithium phase gives lithium compounds, together with lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, corresponding to butyllithium and lithium aluminum hydride to be used in lithium batteries for shopper electronics and electrical automobiles, excessive efficiency greases, thermoplastic elastomers for automobile tires, rubber soles, plastic bottles, catalysts for chemical reactions, natural synthesis processes within the areas of steroid chemistry and nutritional vitamins, life sciences, pharmaceutical trade, and different markets.
Featured Tales
This instantaneous information alert was generated by narrative science expertise and monetary information from MarketBeat to be able to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to [email protected]
Should you invest $1,000 in Albemarle right now?
Earlier than you contemplate Albemarle, you will need to hear this.
MarketBeat retains observe of Wall Road’s top-rated and greatest performing analysis analysts and the shares they advocate to their purchasers every day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Albemarle wasn’t on the checklist.
Whereas Albemarle at the moment has a “Purchase” score amongst analysts, top-rated analysts consider these 5 shares are higher buys.
from NYSE Updates – My Blog https://ift.tt/sivK3dN
via IFTTT
No comments:
Post a Comment